Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-134153
Filing Date
2024-12-06
Accepted
2024-12-06 16:35:04
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3757
  Complete submission text file 0000950170-24-134153.txt   5289
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043
Business Address
Fairey William (Reporting) CIK: 0001727275 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 241532815